The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
Open accessAbstract
Necrotizing and crescentic GN (NCGN) with a paucity of glomerular immunoglobulin deposits is associated with ANCA. The most common ANCA target antigens are myeloperoxidase (MPO) and proteinase 3. In a manner that requires activation of the alternative complement pathway, passive transfer of antibodies to mouse MPO (anti-MPO) induces a mouse model of ANCA NCGN that closely mimics human disease. Here, we confirm the importance of C5aR/CD88 in the mediation of anti-MPO-induced NCGN and report that C6 is not required. We further demonstrate that deficiency of C5a-like receptor (C5L2) has the reverse effect of C5aR/CD88 deficiency and results in more severe disease, indicating that C5aR/CD88 engagement enhances inflammation and C5L2 engagement suppresses inflammation. Oral administration of CCX168, a small molecule antagonist of human C5aR/CD88, ameliorated anti-MPO-induced NCGN in mice expressing human C5aR/CD88. These observations suggest that blockade of C5aR/CD88 might have therapeutic benefit in patients with ANCA-associated vasculitis and GN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Xiao, H., Heeringa, P., Hu, P., Liu, Z., Zhao, M., Aratani, Y., Maeda, N., Falk, R. J., & Jennette, J. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15918 · Cited by 1,005
Self-citationXiao, H., Heeringa, P., Hu, P., Liu, Z., Zhao, M., Aratani, Y., Maeda, N., Falk, R. J., & Jennette, J. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215918 · Cited by 919
Self-citationXiao, H., Schreiber, A., Heeringa, P., Falk, R. J., & Jennette, J. C. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060573 · Cited by 579
Self-citationPredominant role for C5b-9 in renal ischemia/reperfusion injury
Zhou, W., Farrar, C. A., Abe, K., Pratt, J. R., Marsh, J. E., Wang, Y., Stahl, G. L., & Sacks, S. H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8621 · Cited by 465
Self-citationC5a Receptor Mediates Neutrophil Activation and ANCA-Induced Glomerulonephritis
Schreiber, A., Xiao, H., Jennette, J. C., Schneider, W., Luft, F. C., & Kettritz, R. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050497 · Cited by 451
Self-citationThe complement system in systemic autoimmune disease
Chen, M., Daha, M. R., & Kallenberg, C. G. M. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.014 · Cited by 327
Huugen, D., van Esch, A., Xiao, H., Peutz-Kootstra, C.-J., Buurman, W.-A., Tervaert, J. W. C., Jennette, J.-C., & Heeringa, P. (2007) · Kidney International · doi:10.1038/sj.ki.5002103 · Cited by 249
Self-citationThe C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction
Bamberg, C. E., Mackay, C. R., Lee, H., Zahra, D., Jackson, J., Lim, Y. S., Whitfeld, P. L., Craig, S., Corsini, E., Lu, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.092106 · Cited by 249
Self-citationPathogenesis of Antineutrophil Cytoplasmic Autoantibody–Associated Small-Vessel Vasculitis
Jennette, J. C., Falk, R. J., Hu, P., & Xiao, H. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132453 · Cited by 243
Self-citationAn Anti-inflammatory Function for the Complement Anaphylatoxin C5a-binding Protein, C5L2
Gerard, N. P., Lu, B., Liu, P., Craig, S., Fujiwara, Y., Okinaga, S., & Gerard, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500287200 · Cited by 201
Self-citationWalters, M. J., Wang, Y., Lai, N., Baumgart, T., Zhao, B. N., Dairaghi, D. J., Bekker, P. J., Ertl, L. S., Penfold, M. E. T., Jaén, J. C., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.169714 · Cited by 173
Self-citationThe human complement fragment receptor, C5L2, is a recycling decoy receptor
Scola, A.-M., Johswich, K. O., Morgan, B. P., Klos, A., & Monk, P. N. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.11.001 · Cited by 140
Banda, N. K., Hyatt, S., Antonioli, A. H., White, J. T., Glogowska, M. J., Takahashi, K., Merkel, T. J., Stahl, G. L., Mueller‐Ortiz, S. L., Wetsel, R. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102310 · Cited by 137
Hao, J., Meng, L., Xu, P., Chen, M., & Zhao, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038317 · Cited by 85
Lee, H., Zahra, D., Vogelzang, A., Newton, R. A., Thatcher, J., Quan, A., So, T., Zwirner, J., Köentgen, F., Padkjær, S. B., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1248 · Cited by 66
C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies
Carrera‐Marin, A. L., Romay‐Penabad, Z., Papalardo, E., Reyes‐Maldonado, E., Garcı́a-Latorre, E., Vargas, G., Shilagard, T., & Pierangeli, S. S. (2012) · Lupus · doi:10.1177/0961203312458839 · Cited by 61
Dairaghi, D. J., Zhang, P., Wang, Y., Seitz, L. C., Johnson, D. A., Miao, S., Ertl, L. S., Zeng, Y., Powers, J. P., Pennell, A. M. K., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.33 · Cited by 58
Self-citationGenetically Determined Severity of Anti-Myeloperoxidase Glomerulonephritis
Xiao, H., Ciavatta, D. J., Aylor, D. L., Hu, P., de Villena, F. P., Falk, R. J., & Jennette, J. C. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.12.006 · Cited by 24
Self-citation
Cited by
RETRACTED: Avacopan for the Treatment of ANCA-Associated Vasculitis
Jayne, D. R. W., Merkel, P. A., Schall, T. J., & Bekker, P. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2023386 · Cited by 1,021
Self-citationRetractedAlmaani, S., Meara, A., & Rovin, B. H. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05780616 · Cited by 930
Kitching, A. R., Anders, H.-J., Basu, N., Brouwer, E., Gordon, J., Jayne, D. R., Kullman, J., Lyons, P. A., Merkel, P. A., Savage, C. O. S., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0204-y · Cited by 928
Neutrophils as emerging therapeutic targets
Németh, T., Sperandio, M., & Mócsai, A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0054-z · Cited by 653
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
Jayne, D. R. W., Bruchfeld, A. N., Harper, L., Schaier, M., Venning, M. C., Hamilton, P., Burst, V., Grundmann, F., Jadoul, M., Szombati, I., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016111179 · Cited by 607
Self-citation
Metadata
- Authors
- Xiao, H., Dairaghi, D. J., Powers, J. P., Ertl, L. S., Baumgart, T., Wang, Y., Seitz, L. C., Penfold, M. E. T., Gan, L., Hu, P., Lu, B., Gerard, N. P., Gerard, C., Schall, T. J., Jaen, J. C., Falk, R. J., & Jennette, J. C.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2014-02
- Volume
- 25
- Issue
- 2
- Pages
- 225-231
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2143558168
- Cited by
- 353
- References
- 18
- FWCI
- 17.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.